enGene Holdings Inc. Annual Earnings Per Share, Diluted in USD/shares from 2022 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
enGene Holdings Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from 2022 to 2023.
  • enGene Holdings Inc. Earnings Per Share, Diluted for the quarter ending July 31, 2024 was 0.32 USD/shares, a 96.3% decline year-over-year.
  • enGene Holdings Inc. Earnings Per Share, Diluted for the twelve months ending July 31, 2024 was 121 USD/shares.
  • enGene Holdings Inc. annual Earnings Per Share, Diluted for 2023 was 151 USD/shares, a 241% increase from 2022.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $151 +$107 +241% Nov 1, 2022 Oct 31, 2023 10-K 2024-01-29
2022 $44.30 Nov 1, 2021 Oct 31, 2022 10-K 2024-01-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.